Stay informed with the latest updates for the inheritable blood disorders community. Medical New Documents Cover Bleeding Disorders, Bone Health, Mental Health…Oct 30, 2024 Medical FDA Approves Pfizer's HYMPAVZI for Hemophilia A and B TreatmentOct 14, 2024 Medical Support Networks and Clinical Trials the Focus of Upcoming FDA WebinarOct 11, 2024 Medical CHOP Researchers Investigate Durability of Hemophilia A Gene TherapyOct 11, 2024 Medical Enduring Education Focuses on Hemophilia Non-Factor Replacement TherapyAug 30, 2024 Industry BioMarin to Narrow Its Commercial Focus for Hemophilia A Gene TherapyAug 13, 2024 Medical Attention Clinicians! New Bleeding Disorders Education Available from IHSAug 6, 2024 Industry Pfizer Announces New Data from Hemophilia A Gene Therapy StudyAug 1, 2024 Medical Pfizer Presents Marstacimab Trial Updates at EHA Annual MeetingJul 18, 2024 Medical Activity Looks at Non-Factor Replacement Therapy in Hemophilia Clinical…Jul 17, 2024 Medical Learn About Clinical Issues in Women with Bleeding Disorders Jun 18, 2024 Medical Explore Videos on Clinical Issues in Novel Treatment ModalitiesJun 18, 2024 Medical Study Suggests Prophylaxis Can Mitigate Intracranial Hemorrhage RiskMay 23, 2024 Industry FDA Approval Includes Full ALTUVIIIO™ Pediatric Trial Results May 17, 2024 Medical First Sickle Cell Patient to Receive Gene Therapy Featured in NYT May 10, 2024 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page